Key result
rsDMAS beamformer improves contrast ratio by ~39% versus FMAS while boosting CNR and SNR.
Why the study?
Although ultrasound power Doppler imaging provides superior sensitivity for blood flow visualization, further enhancement in imaging quality remains necessary for more precise clinical diagnoses.
The novel rsDMAS beamformer significantly enhances ultrasound power Doppler imaging quality by improving contrast and signal-to-noise ratios.
rsDMAS beamformer may enhance power Doppler quality; leaves open clinical validation before diagnostic adoption.
Ultrasound power Doppler imaging serves as an essential diagnostic modality for blood flow visualization in clinical practice, demonstrating superior sensitivity relative to conventional color Doppler imaging. Despite its advantages, further enhancement in imaging quality remains imperative to achieve more precise clinical diagnoses. This study introduces an innovative power Doppler imaging technique incorporating a regional-lag signed delay multiply and sum (rsDMAS) beamformer to improve contrast performance. The proposed rsDMAS algorithm overcomes existing technical limitations through dynamic optimization of the maximum lag parameter for coherence estimation, effectively amplifying blood flow signals while maintaining the integrity of weaker vascular signals. Furthermore, the implementation of a clutter filter on aperture-compounded signals successfully addresses phase distortion artifacts that would otherwise compromise imaging quality. Comprehensive validation through both simulation and in vivo experiments revealed substantial performance improvements: contrast ratio (CR) enhancements of 39 and 10.7%, contrast-to-noise ratio (CNR) improvements of 9 and 55.8%, and signal-to-noise ratio (SNR) gains of 40 and 7.8% compared to frame multiply and sum (FMAS) and delay multiply and sum (DMAS) methods, respectively. The developed technique demonstrates robust suppression of thermal noise and acoustic clutter, ultimately yielding significantly enhanced blood flow imaging capabilities for clinical applications.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied blood flow visualization. regional-lag signed delay multiply and sum (rsDMAS) beamformer vs. frame multiply and sum (FMAS) and delay multiply and sum (DMAS) methods was evaluated on contrast ratio (CR), contrast-to-noise ratio (CNR), and signal-to-noise ratio (SNR). The rsDMAS beamformer improved contrast ratio by 39% and 10.7%, CNR by 9% and 55.8%, and SNR by 40% and 7.8% compared to FMAS and DMAS methods, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: